Eastern Cooperative Oncology Group: Leukemia trials
The registry lists 23 Leukemia studies with Eastern Cooperative Oncology Group as lead sponsor. 1 are open to participants now and 5 have results posted.
Phase 2 9Phase 3 7No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial TreatmentNot yet recruitingNCT05628623Phase 2
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLLCompletedNCT00074282Phase 2Results posted
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML LeukemiaCompletedNCT00049517Phase 3Results posted
- Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory AnemiaCompletedNCT00046930Phase 3Results posted
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesCompletedNCT00045305Phase 2Results posted
- Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic LeukemiaTerminatedNCT00003910Phase 2Results posted
- Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic LeukemiaCompletedNCT04446052Phase 3
- Studying Genes in Samples From Younger Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT01653613
- Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic LeukemiaCompletedNCT01505699
- Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid LeukemiaCompletedNCT01421875
- Biomarkers in Blood Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01385150
- Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based TherapyCompletedNCT01145469
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical TrialCompletedNCT00897767
- Study of Bone Marrow Samples From Patients With Acute LeukemiaCompletedNCT00897559
- Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionWithdrawnNCT00101140Phase 2
- Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00006390Phase 2
- flt3L in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00006223Phase 3
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNCT00006008Phase 2
- Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous LeukemiaCompletedNCT00005962Phase 2
- Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00003808Phase 2
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003764Phase 3
- Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous LeukemiaCompletedNCT00002868Phase 3
- Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First RemissionCompletedNCT00002514Phase 3